Skip to content
OpenCapital
Get started

Senti Biosciences SNTI Q1 2025 earnings

Reported May 6, 2025 · Before market open

EPS-$1.41Miss by $0.83
Revenue estimate$1.3M
EPS estimate-$0.58

Next report

Aug 6, 2026 (In 1 week)
Revenue estimate$14.9K
EPS estimate-$0.33

Versus estimates

Revenue

Q1 2026$16.0KQ4 2025$22.0KMiss by $978.0KQ4 2024$5.9MBeat by $3.1M

Diluted EPS

Q1 2026-$0.36Miss by $0.09Q4 2025-$0.38Beat by $0.05Q3 2025-$0.69Miss by $0.10Q2 2025-$0.56Beat by $0.34
Q1 2025-$1.41Miss by $0.83
Q4 2024-$0.67Beat by $2.46

Ask the moment Senti Biosciences reports.

Connect your AI and ask the moment the filing drops. It reads the release, surfaces what management said, and gives you its own read.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

When did Senti Biosciences report Q1 2025 earnings?
Senti Biosciences (SNTI) reported Q1 2025 earnings on May 6, 2025 before market open.
What were Senti Biosciences's Q1 2025 revenue and EPS?
Senti Biosciences reported eps of $-1.41 for Q1 2025.
Did Senti Biosciences beat estimates in Q1 2025?
EPS missed the consensus estimate of $-0.58 by $0.83.
How did Senti Biosciences's Q1 2025 results compare year-over-year?
Compared to the same quarter a year prior, eps grew 45.8% from $-2.60.
Where can I find Senti Biosciences's Q1 2025 SEC filings?
You can read the 10-Q periodic report (0001854270-25-000065) directly on SEC EDGAR. The filing index links above go to sec.gov.